◆ 会议时间：2022年4月28-30日
◆ 会议地点：瑞士 卢加诺（Lugano）

◆ 会议简介：

2022年晚期前列腺癌共识大会(APCCC)将于2022年4月28-30日在瑞士卢加诺Lugano举行，会议由晚期前列腺癌学会(APC)主办。APC学会是一个非营利性组织，其宗旨是改善晚期前列腺癌患者的治疗和护理。APCCC为从事晚期前列腺癌领域的医学专业人士和其他参与者来提供了一个独特的机会，他们可以参加最新的讲座，并与国际前列腺癌专家互动，了解他们日常实践的真实经验。APCCC旨在提供一个论坛，以讨论和辩论当前有关晚期前列腺癌患者临床管理的问题，会议有两天时间致力于高水准的陈述、讨论和辩论，以总结和概念化现有的文献和证据。会议最后由一个跨学科专家小组针对临床相关目标领域的预定义共识问题进行投票表决。会议结束后，一份带有这些专家建议的手稿将在同行评审的期刊上发表（2015年：Annals of Oncology；2017年：European Urology）。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

Aims of APCCC

• Provide an update on the current standard of advanced prostate cancer management with a focus on situations with no high level evidence for a specific treatment option.
• Advanced prostate cancer is defined by APCCC as locally advanced disease, biochemical recurrence, and metastatic disease.
• Offer a highly educational program consisting of invited lectures, debates, and discussions led by a panel of international and interdisciplinary prostate cancer experts.lingyint.
• Translate knowledge by summarising and conceptualising current standards of advanced prostate cancer management and disseminating the results of consensus discussions and voting.
• At the end of the meeting, convene these experts to discuss and vote on predefined questions regarding key areas of debate or lack of evidence regarding the optimal treatment of men with advanced prostate cancer. The conference and the development of these questions have been described in detail (see APCCC 2015 and APCCC 2017)
• After the meeting, publish the consensus summary in a high-impact medical journal.
• Conference attendees will be able to participate in the two days of discussions as well as the consensus panel discussion. Attendees are encouraged to interact with panel members to facilitate and encourage international collaboration.